These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 15390194

  • 1. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
    Yau TK, Sze WM, Lee WM, Yeung MW, Leung KC, Hung WM, Chan WI.
    Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 3. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ, Kong L, Shakespeare TP, Loh KS, Zhang Q, Tan KS, Lee KM.
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [Abstract] [Full Text] [Related]

  • 4. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.
    Yeo R, Fong KW, Hee SW, Chua ET, Tan T, Wee J.
    Head Neck; 2009 Dec; 31(12):1610-8. PubMed ID: 19536853
    [Abstract] [Full Text] [Related]

  • 5. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.
    Wu SX, Chua DT, Deng ML, Zhao C, Li FY, Sham JS, Wang HY, Bao Y, Gao YH, Zeng ZF.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):761-9. PubMed ID: 17601682
    [Abstract] [Full Text] [Related]

  • 6. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
    Leung TW, Wong VY, Sze WK, Lui CM, Tung SY.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):361-7. PubMed ID: 17892917
    [Abstract] [Full Text] [Related]

  • 7. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
    Teo PM, Leung SF, Tung SY, Zee B, Sham JS, Lee AW, Lau WH, Kwan WH, Leung TW, Chua D, Sze WM, Au JS, Yu KH, O SK, Kwong D, Yau TK, Law SC, Sze WK, Au G, Chan AT.
    Radiother Oncol; 2006 Apr 01; 79(1):27-33. PubMed ID: 16626829
    [Abstract] [Full Text] [Related]

  • 8. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
    Leung TW, Tung SY, Wong VY, Sze WK, Lui CM, Wong FC, Lee AS, O SK.
    Cancer; 2005 Oct 15; 104(8):1648-55. PubMed ID: 16118806
    [Abstract] [Full Text] [Related]

  • 9. Fractionated stereotactic radiotherapy in residual or recurrent nasopharyngeal carcinoma.
    Dhanachai M, Kraiphibul P, Dangprasert S, Puataweepong P, Narkwong L, Laothamatas J, Kulapraditharom B, Sirachainan E, Yongvithisatid P.
    Acta Oncol; 2007 Oct 15; 46(6):828-33. PubMed ID: 17653907
    [Abstract] [Full Text] [Related]

  • 10. Recurrent nasopharyngeal carcinoma: current management approaches.
    Smee RI, Meagher NS, Broadley K, Ho T, Williams JR, Bridger GP.
    Am J Clin Oncol; 2010 Oct 15; 33(5):469-73. PubMed ID: 19935385
    [Abstract] [Full Text] [Related]

  • 11. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.
    Kwong DL, Wei WI, Cheng AC, Choy DT, Lo AT, Wu PM, Sham JS.
    Cancer; 2001 Mar 15; 91(6):1105-13. PubMed ID: 11267955
    [Abstract] [Full Text] [Related]

  • 12. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
    Hara W, Loo BW, Goffinet DR, Chang SD, Adler JR, Pinto HA, Fee WE, Kaplan MJ, Fischbein NJ, Le QT.
    Int J Radiat Oncol Biol Phys; 2008 Jun 01; 71(2):393-400. PubMed ID: 18164839
    [Abstract] [Full Text] [Related]

  • 13. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A, Lin K, Tiong CE, Tan LK, Loh TK, Goh BC, Lu JJ.
    Laryngoscope; 2006 Jun 01; 116(6):938-43. PubMed ID: 16735885
    [Abstract] [Full Text] [Related]

  • 14. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma.
    Low JS, Chua ET, Gao F, Wee JT.
    Head Neck; 2006 Apr 01; 28(4):321-9. PubMed ID: 16287135
    [Abstract] [Full Text] [Related]

  • 15. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
    Yu KH, Leung SF, Tung SY, Zee B, Chua DT, Sze WM, Law SC, Kam MK, Leung TW, Sham JS, Lee AW, Au JS, Hui EP, Sze WK, Cheng AC, Yau TK, Ngan RK, Wong FC, Au GK, Chan AT, Hong Kong Nasopharyngeal Carcinoma Study Group.
    Head Neck; 2005 May 01; 27(5):397-405. PubMed ID: 15726589
    [Abstract] [Full Text] [Related]

  • 16. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT, Wei WI, Sham JS, Cheng AC, Au G.
    Head Neck; 2003 Jul 01; 25(7):585-94. PubMed ID: 12808662
    [Abstract] [Full Text] [Related]

  • 17. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
    Zheng XK, Chen LH, Chen YQ, Deng XG.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):165-70. PubMed ID: 15337552
    [Abstract] [Full Text] [Related]

  • 18. Treatment results of 59 young patients with nasopharyngeal carcinoma.
    Selek U, Ozyar E, Ozyigit G, Varan A, Buyukpamukcu M, Atahan IL.
    Int J Pediatr Otorhinolaryngol; 2005 Feb 01; 69(2):201-7. PubMed ID: 15656953
    [Abstract] [Full Text] [Related]

  • 19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.